Company profile: Aptuit
1.1 - Company Overview
Company description
- Provider of integrated CRO/CDMO services spanning early discovery to mid-phase drug development, including drug design and discovery, API development and manufacture, solid state chemistry, CMC, preclinical, and IND-enabling GLP/GMP programs. Offers an AI-powered PanOmics platform, iPSC-based disease modeling, molecular glue degraders, neuroscience drug discovery, and biosimilar development via a partnership with Sandoz.
Products and services
- CRO/CDMO Services: GLP/GMP-compliant contract research and manufacturing covering Drug Design & Discovery, API Development and Manufacture, Solid State Chemistry, CMC, Preclinical, IND enabling, from disease understanding to Phase 1 and beyond
- Neuroscience Drug Discovery: Precision medicine-qualified technologies drive drug discovery and development in neurodegenerative diseases, enabling targeted discovery approaches and progression of assets in this therapeutic domain
- PanOmics Platform: AI-powered R&D platform strengthens disease understanding and human relevance, generating actionable insights that inform discovery program design and interpretation
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Aptuit
Clinvest Research
HQ: United States
Website
- Description: Provider of clinical research services conducting clinical trials for headache and migraine, arthritis and joint pain, diabetes and weight management, and vaccines (flu, RSV, COVID). Partners with pharmaceutical companies to study and develop new treatments and health strategies, providing participants access to new treatments before they are widely available.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Clinvest Research company profile →
EMD Millipore
HQ: United States
Website
- Description: Provider of biopharmaceutical manufacturing solutions including cell culture media, filtration and purification systems; life science research tools and reagents for genomic analysis, protein sample preparation, antibodies, assays and small molecule research; laboratory water purification systems and consumables; microbial testing for pharma, cosmetics, food, beverages and municipal water; IVD/OEM kits, materials and reagents; and chemicals, reagents and labware.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full EMD Millipore company profile →
Halloran Consulting Group
HQ: United States
Website
- Description: Provider of help for life science companies to achieve excellence in regulatory, quality, and clinical development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Halloran Consulting Group company profile →
EirGen Pharma
HQ: Ireland
Website
- Description: Provider of high potency oral solid dose medicines for human and veterinary use and contract development, manufacturing, and packaging services for the global pharmaceutical market, including research, formulation, and analytical development and investigational medicinal products. Fully licensed to manufacture oncology, cytotoxic, steroidal, and immunosuppressant molecules in purpose-built high containment suites, covering film-coated tablets, soft-gel, and hard-shell capsules.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full EirGen Pharma company profile →
Colorcon
HQ: United States
Website
- Description: Provider of specialty excipients, film coatings (immediate, enteric, sustained release), and functional packaging for solid oral dosage forms in pharmaceutical, nutritional, and animal health markets. Provides formulation support to enhance adherence, reduce medication errors, and add brand value. Products include Opadry, Acryl-EZE, Surelease, Starch 1500, METHOCEL, and StarTab, plus label-friendly solutions for dietary supplements.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Colorcon company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Aptuit
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Aptuit
2.2 - Growth funds investing in similar companies to Aptuit
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Aptuit
4.2 - Public trading comparable groups for Aptuit
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →